Adult Learning Theory
How adult learning principles apply to physician engagement in rare disease — and why traditional approaches fall short.
Best Practices in Rare Disease Commercialization
Strategies for launching and commercializing rare disease therapies — from market access to physician engagement.
Content Marketing for Rare Diseases
Why content marketing in rare disease requires a fundamentally different approach — and how to get it right.
The Education Gap
The gap between rare disease awareness and physician readiness — and what it means for patients waiting on a diagnosis.
Genetic Testing
The role of genetic testing in rare disease diagnosis — and how physician engagement can accelerate the path to testing.
Interactive Education
Why interactive content formats outperform passive engagement in rare disease — and the data to prove it.
Nothing About Us Without Us
Patient advocacy and the role of lived experience in shaping rare disease engagement and research priorities.
Personal Experience
How personal connections to rare disease shape better physician engagement — and why it matters for patient outcomes.
Raising the Baseline
Elevating the baseline of physician knowledge in rare disease — why incremental engagement compounds into clinical readiness.
AI and the Future of Rare Disease Care
How artificial intelligence is reshaping rare disease diagnosis, drug development, and the clinical workforce.
Rare Diseases vs. Rare Tumor Types
A comparative analysis of epidemiology, diagnostic pathways, regulatory frameworks, and clinical management strategies.
Defining the Disease
Why the most durable pharma launches are built on biological understanding, not brand identity — with case studies in SMA, Gaucher disease, and hereditary ATTR amyloidosis.
Why HCPs Seek Rare Disease Information
Why HCPs actually go looking for rare disease information — and why it isn’t curiosity driving the search.
